Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16782971

Download in:

View as

General Info

PMID
16782971